Table 4 Pregnancy outcomes of patients undergoing endometrial injury in proliferative phase, luteal phase and control groups
Variable | Group A | Group B | Group C | Group D | P value |
|---|---|---|---|---|---|
(n = 38) | (n = 32) | (n = 36) | (n = 36) | ||
Implantation rate | 24/80(30.0%) | 16/67(23.9%) | 19/74(25.7%) | 20/72 (27.8%) | 0.853 |
Biochemical pregnancy rate | 20/38(52.6%) | 18/32(56.3%) | 19/36(52.8%) | 19/36 (52.8%) | 0.989 |
Clinical pregnancy rate | 16/38(42.1%) | 13/32(40.6%) | 16/36(44.4%) | 14/36 (38.9%) | 0.970 |
Miscarriage rate | 1/16(6.3%) | 0/13(0.0%) | 0/16 (0.0%) | 1/14(7.1%) | 0.568 |
Ectopic pregnancy rate | 0/16(0.0%) | 1/13(7.7%) | 0/16 (0.0%) | 0/14(0.0%) | 0.308 |
Multiple pregnancy rate | 7/16(38.9%) | 3/13(23.1%) | 3/16 (18.8%) | 6/14(42.9%) | 0.401 |
Live birth rate | 15/38(39.5%) | 10/32(31.3%) | 16/36(44.4%) | 13/36 (36.1%) | 0.719 |